1-4 of 4
Diane L. McNally, BSPharm, M.S.
Close
Sort by
Journal Articles

Utilization Patterns of Iron Chelation Therapy in Transfusion-Dependent Myelodysplastic Syndrome Patients Enrolled in Medicare Part D.

Amer M. Zeidan, MD, Maria R. Baer, M.D., Steven D. Gore, MD, Medha Sasane, BPharm, PhD, Carole Paley, MD, Diane L. McNally, BSPharm, M.S., Amy J. Davidoff, M.S., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 3178.
https://doi.org/10.1182/blood.V120.21.3178.3178
Published: 2012
Journal Articles

Lenalidomide Performance in the Real World: Patterns of Utilization and Effectiveness in a Medicare Population with Myelodysplastic Syndromes

Amer M. Zeidan, MD, Steven D. Gore, MD, Diane L. McNally, BSPharm, M.S., Maria R. Baer, M.D., Franklin Hendrick, B.S., Dalia Mahmoud, MBA, Amy J. Davidoff, M.S., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 3837.
https://doi.org/10.1182/blood.V120.21.3837.3837
Published: 2012
Journal Articles

Deferasirox Is Associated with Reduced Mortality Risk in a Medicare Population with Myelodysplastic Syndromes

Amer M. Zeidan, MD, Franklin Hendrick, B.S., Erika Friedmann, PhD, Steven D. Gore, MD, Maria R. Baer, M.D., Medha Sasane, BPharm, PhD, Carole Paley, MD, Diane L. McNally, BSPharm, M.S., Amy J. Davidoff, M.S., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 426.
https://doi.org/10.1182/blood.V120.21.426.426
Published: 2012
Journal Articles

Access to Care, Race and Education Are Key Determinants of Erythropoietin Stimulating Agent (ESA) Use In Myelodysplastic Syndromes (MDS).

Amy J. Davidoff, PhD, M.S., Sheila Weiss Smith, PhD, Maria R Baer, M.D., Xuehua Ke, M.A., Jason M Bierenbaum, M.D., Franklin Hendrick, B.S., Diane L. McNally, BSPharm, M.S., Steven D. Gore, M.D.
Journal: Blood
Blood (2010) 116 (21): 3815.
https://doi.org/10.1182/blood.V116.21.3815.3815
Published: 2010